Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 2, 2011, Pages 157-164

  Morrison, Charles S ^a   Chen, Pai Lien ^b   Nankya, Immaculate ^c   Rinaldi, Anne ^a   Van Der Pol, Barbara ^d   Ma, Yun Rong ^b   Chipato, Tsungai ^e   Mugerwa, Roy ^f   Dunbar, Megan ^g   Arts, Eric ^h   Salata, Robert A ^h  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b Department of Biostatistics Family Health International ^*  (United States)

^c JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF ZIMBABWE   (Zambia)

^f MAKERERE UNIVERSITY   (Uganda)

^g RTI INTERNATIONAL   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

disease progression; family planning; HIV; hormonal contraception; women

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; UGANDA; VIRUS LOAD; ZIMBABWE;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL; DELAYED-ACTION PREPARATIONS; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MEDROXYPROGESTERONE ACETATE; UGANDA; YOUNG ADULT; ZIMBABWE;

EID: 79957963576     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318214ba4a     Document Type: Article

References (33)

1. AIDS Epidemic Update, November 2009. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2009.
2. Hoffman IF, Martinson FE, Powers KA, et al. The year-long effect of HIVpositive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. J Acquir Immune Defic Syndr. 2008;47:477-483. (Pubitemid 351366969)
3. Desgrees-Du-Lou A, Msellati P, Viho I, et al. Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIVinfected women. DITRAME ANRS 049 Project, Abidjan 1995-2000. Int J STD AIDS. 2002;13:462-468. (Pubitemid 34753811)
4. United Nations Family Planning Association (UNFPA). UNFPA Annual Report 2000. New York: United Nations Population Fund; 2001.
5. World Health Organization (WHO), United Nations Family Planning Association (UNFPA). Glion Consultation on Strenghtening the Linkages Between Reproductive Health and HIV/AIDS: Family Planning and HIV/ AIDS in Women and Children. Geneva: WHO; 2006.
6. Reynolds HW, Janowitz B, Homan R, et al. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis. 2006;33:350-356. (Pubitemid 43833021)
7. Halperin DT, Stover J, Reynolds HW. Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS. 2009;23(Suppl 1):S123-S130.
8. Mugo N, Heffron R, Donnell D, et al. Pregnancy is associated with an increased risk for HIV transmission among African HIV-1 serodiscordant couples. Paper presented at: Microbicides 2010; May 23, 2010; Pittsburgh, PA.
9. World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use, 4th ed. Geneva: WHO; 2010.
10. Lavreys L, Baeten JM, Kreiss JK, et al. Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis. 2004;189:303-311. (Pubitemid 38147255)
11. Stringer EM, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007;197:144-148.
12. Stringer EM, Levy J, Sinkala M, et al. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS. 2009;23:1377-1382.
13. Richardson BA, Otieno PA, Mbori-Ngacha D, et al. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. AIDS. 2007;21:749-753. (Pubitemid 46568632)
14. Cejtin HE, Jacobson L, Springer G, et al. Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women. AIDS. 2003;17:1702-1704. (Pubitemid 36951695)
15. Stringer EM, Giganti M, Carter RJ, et al. Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCTPlus Initiative. AIDS. 2009;23(Suppl 1):S69-S77.
16. Allen S, Stephenson R,Weiss H, et al. Pregnancy, hormonal contraceptive use, and HIV-related death in Rwanda. J Womens Health. Sep 2007;16: 1017-1027. (Pubitemid 47479946)
17. Kilmarx PH, Limpakarnjanarat K, Kaewkungwal J, et al. Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand. J Infect Dis. 2000;181:1598-1606. (Pubitemid 30387750)
18. Polis CB,Wawer MJ, Kiwanuka N, et al. Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda. AIDS. 2010;24:1937-1944.
19. Morrison CS, Demers K, Kwok C, et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS. 2010;24:573-582.
20. Morrison CS, Richardson BA, Mmiro F, et al. Hormonal contraception and the risk of HIV acquisition. AIDS. 2007;21:85-95. (Pubitemid 44912541)
21. Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis. 2007;45:360-369. (Pubitemid 47101035)
22. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-560. (Pubitemid 30660034)
23. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the joint causal effect of nonrandomized treatments. J Am Stat Assoc. 2001;96:440-448.
24. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989;84:1074-1078.
25. Curtis KM, Nanda K, Kapp N. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS. 2009;23(Suppl 1):S55-S67.
26. Esbjornsson J, Mansson F, Martinez-Arias W, et al. Frequent CXCR4 tropism of HIV-1 subtype A and CRF02-AG during late-stage disease-indication of an evolving epidemic in West Africa. Retrovirology. 2010;7:23.
27. Sagar M, Lavreys L, Baeten JM, et al. Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. AIDS. 2004;18:615-619. (Pubitemid 38393460)
28. Bonnet F, Thiebaut R, Chene G, et al. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002. HIV Med. 2005;6:198-205. (Pubitemid 40740337)
29. Lovvorn AE, Patnaik P, Walker CJ, et al. Variations in CD4 cell counts among HIV-uninfected and infected women in Uganda and Zimbabwe. Int J STD AIDS. 2010;21:342-345.
30. Kiwanuka N, Laeyendecker O, Robb M, et al. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis. 2008;197:707-713. (Pubitemid 351364471)
31. Baeten JM, Chohan B, Lavreys L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis. 2007;195:1177-1180. (Pubitemid 46543449)
32. Kaleebu P, French N, Mahe C, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis. 2002; 185:1244-1250. (Pubitemid 34439131)
33. Senkaali D, Muwonge R, Morgan D, et al. The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort. AIDS Res Hum Retroviruses. 2004;20:932-937. (Pubitemid 39369699)